Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Dr Robert Beagrie, a postdoc in the research group of Prof Doug Higgs at the MRC Molecular Haematology Unit (Radcliffe Department of Medicine)! Robert was a awarded a prestigious Sir Henry Wellcome Postdoctoral Fellowship, a four-year award that offers recently qualified postdoctoral researchers the opportunity to start independent research careers.

Robert Beagrie

Robert will be working with Prof Doug Higgs and Assoc. Prof. Merav Socolovsky (University of Massachusetts Medical School) to study gene regulation in early red blood cell progenitors. Rob’s project will investigate how DNA regulatory elements called enhancers drive the activation of thousands of genes as these cells enter terminal differentiation, during a fascinating transition point that is tightly synchronised with the cell cycle. Before moving to the MRC WIMM Robert did a PhD in the lab of Prof Ana Pombo at the Max Delbrück Center for Molecular Medicine in Berlin, where he developed a new method for measuring how DNA folds inside cells.

Similar stories

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.

Immune cells imperfect at distinguishing friend from foe

When it comes to distinguishing a healthy cell from an infected one that needs to be destroyed, the immune system’s killer T cells sometimes make mistakes. This discovery, described today in the journal eLife, upends a long-held belief among scientists that T cells were nearly perfect at discriminating friend from foe. The results may point to new ways to treat autoimmune diseases that cause the immune system to attack the body, or lead to improvements in cutting-edge cancer treatments.

Professor Graham Ogg elected Academy of Medical Sciences Fellow

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

New funding for early diagnosis research using platelets

Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.